Speaker Profile

Ph.D., Executive Director, Center for Microbiome Innovation; Professor of Practice, Bioengineering, UCSD

Dr. Sandrine Miller-Montgomery’s team is focused on expanding industry and academic collaborations of microbiome research in the consumer world as well as enabling major clinical breakthroughs. Previously, she led MO BIO Laboratories, now a QIAGEN Company, having started as their director of sales and marketing where her team contributed to the consistent business growth resulting in its acquisition by QIAGEN. She has held global marketing management positions at large companies such as Abbott Laboratories, Illumina, and Invitrogen (now part of Thermo Fisher), and originally came from France in 2000 to join Genset in their R&D department. Sandrine received both her PharmD and her PhD in Life Science from the University of Bordeaux (France), with an emphasis in molecular biology, biology of aging, and thrombosis and hemostasis.

Personalization Of Microbiome Analysis: Why A Longitudinal Multi-Omics And Flobal Approach Is A Must?
Unlike genome, microbiome is highly affected by many parameters such as environment, or diet. We have to study personalized microbiome within a comparable population database to gather proper insights. We will present multi-omics data (including human and food microbiome) that highlight this complex but necessary to address challenge.